share_log

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

現代拉力超過 42%?以下是星期一的 10 個其他價格目標變化
Benzinga Real-time News ·  2022/12/19 08:31
  • Morgan Stanley cut VTEX (NYSE:VTEX) price target from $7 to $5. Â Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
  • Keybanc cut Progyny, Inc. (NASDAQ:PGNY) price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an Overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday.
  • SVB Leerink raised the price target on Roivant Sciences Ltd. (NASDAQ:ROIV) from $8 to $10. SVB Leerink analyst David Risinger maintained an Outperform rating on the stock. Roivant Sciences shares gained 1.1% to close at $7.32 on Friday.
  • Raymond James boosted W. P. Carey Inc. (NYSE:WPC) price target from $80 to $85. Raymond James analyst RJ Milligan maintained an Outperform rating on the stock. W. P. Carey shares fell 0.1% to $79.73 in pre-market trading.
  • Needham raised AtriCure, Inc. (NASDAQ:ATRC) price target from $55 to $58.. Needham analyst Mike Matson maintained a Buy rating on the stock. AtriCure shares fell 2.6% to close at $41.37 on Friday.
  • JP Morgan cut Glaukos Corporation (NYSE:GKOS) price target from $48 to $42. JP Morgan analyst Allen Gong upgraded the stock from Underweight to Neutral. Glaukos shares rose 0.8% to $42.83 in pre-market trading.
  • Jefferies raised Moderna, Inc. (NASDAQ:MRNA) price target from $170 to $275. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday.
  • Stifel boosted Xylem Inc. (NYSE:XYL) price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Xylem shares fell 0.6% to $109.27 in pre-market trading.
  • Piper Sandler raised ConocoPhillips (NYSE:COP) price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an Overweight rating on the stock. ConocoPhillips shares rose 1% to $111.50 in pre-market trading.
  • HC Wainwright & Co. boosted Astria Therapeutics, Inc. (NASDAQ:ATXS) price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis maintained the stock with a Buy rating. Astria Therapeutics shares jumped 4.8% to close at $11.81 on Friday.
  • Baird cut L3Harris Technologies, Inc. (NYSE:LHX) price target from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. L3Harris Technologies shares fell 1.5% to $210.00 in pre-market trading.
  • 摩根士丹利剪VTEX(紐約證券交易所股票代碼:VTEX)目標價從7美元下調至5美元。̂分析師摩根士丹利將該股評級從增持下調至持平。VTEX股價週五下跌4.9%,收於3.52美元。
  • KeyBanc切割Progyny公司(納斯達克:PGNY)目標價從55美元降至45美元。KeyBanc分析師斯科特·舍恩豪斯維持對該股的增持評級。週五,Progyny上漲4.1%,收於31.83美元。
  • SVB Leerink將目標價上調至羅萬特科技有限公司(納斯達克:ROIV)從8美元跌至10美元。SVB Leerink分析師David·裡辛格維持該股表現優於大盤的評級。Roivant Sciences股價上週五上漲1.1%,收於7.32美元。
  • 雷蒙德·詹姆斯提振W.P.凱裡公司(紐約證券交易所代碼:WPC)目標價從80美元降至85美元。Raymond James分析師RJ Milligan對該股維持表現優於大盤的評級。W.P.Carey股價在盤前交易中下跌0.1%,至79.73美元。
  • 李約瑟養大AtriCure,Inc.(納斯達克:ATRC)目標價從55美元降至58美元Needham分析師Mike·馬特森維持對該股的買入評級。AtriCure股價週五下跌2.6%,收於41.37美元。
  • 摩根大通降息格勞科斯公司(紐約證券交易所代碼:GKOS)目標價從48美元降至42美元。摩根大通分析師Allen Gong將該股評級從減持上調至中性。Glaukos股價在盤前交易中上漲0.8%,至42.83美元。
  • 傑富瑞提出Moderna公司(納斯達克)目標價從170美元降至275美元。傑富瑞分析師Michael Yee將該股評級從持有上調至買入。上週五,Moderna股價下跌6.7%,收於193.29美元。
  • Stifel得到提振木質部公司(紐約證券交易所代碼:XYL)目標價從113美元降至115美元。170.Stifel分析師內森·瓊恩斯將該股評級從買入下調至持有。在盤前交易中,XYLEM股價下跌0.6%,至109.27美元。
  • 派珀·桑德勒養大康菲石油(紐約證券交易所代碼:COP)目標價從155美元降至157美元。Piper Sandler分析師瑞安·託德維持對該股的增持評級。在盤前交易中,康菲石油的股價上漲了1%,至111.50美元。
  • HC Wainwright&Co.股價上漲Astria治療公司(納斯達克:ATXS)目標價從13美元升至20美元。HC Wainwright&Co.分析師約瑟夫·潘特吉尼斯將該股評級維持為買入。Astria Treateutics股價週五跳漲4.8%,收報11.81美元。
  • Baird CutL3Harris技術公司(紐約證券交易所代碼:LHX)目標價從290美元降至241美元。Baird分析師Peter Arment將該股評級從強於大盤下調至中性。在盤前交易中,L3Harris Technologies的股價下跌了1.5%,至210.00美元。

Check out this: 4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More

看看這個:內部人士正在買入4只便士股票:Getround、Corvus PharmPharmticals等

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論